跳到主要內容區塊

1.The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases 【發布日期:2022-03-24】 發布單位:

The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases

Hsin-Lin Cheng a, Gow-Chin Yen b,1, Shih-Chien Huang a,c, Shiuan-Chih Chen d,e, Chin-Lin Hsu a,f,*

a Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan

b Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan

c Department of Health Industry Technology Management, Chung Shan Medical University, Taichung, Taiwan

d Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

e Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan

f Department of Nutrition, Chung Shan Medical University Hospital, Taichung, Taiwan

The prevalence of metabolic disease has rising and affected over 1,000 million populations globally. Since the metabolic disease and its related complication are board, it has become the major health hazard of modern world. However, Long term medication of metabolic disease may cause serious side effects and risk for adverse health problems. Recently, emerging studies focus on exploring the mechanistic details of metabolic state in disease development and progression. Gut bacteria ecosystem was considered to play a pivotal role in regulating energy homeostasis and great associated with the development of metabolic disease. Accumulated evidences indicated that Akkermansia muciniphila, Faecalibacterium prausnitzii, and Roseburia hominis improve the balance of the microecology in the intestine of the host and have positive effects on enhancing nutrients absorption. Hence, the novel probiotics as therapeutic target to modify gut microbiota generally focus on improving microbiota dysbiosis, and offers new prospects for treating metabolic disease. In the present review, we discuss the significant roles and regulatory properties of specific bacterium in the context of intestinal microbial balance, explores the kinds of harmful/beneficial bacteria that were likely to act as indicator for metabolic disease. Further proposed a stepwise procedure in the basis of sequencing technology with that of innovative option to reestablish the microbial equilibrium and prevent metabolic disease.

Keywords: Disease prediction, Metabolic disease, Microbiota, Novel probiotics

https://doi.org/10.38212/2224-6614.3396

(https://www.jfda-online.com/journal/vol30/iss1/1/)
檔案下載